Cargando…
Overcoming the Undesirable CRISPR-Cas9 Expression in Gene Correction
The CRISPR-Cas9 system is attractive for gene therapy, as it allows for permanent genetic correction. However, as a new technology, Cas9 gene editing in clinical applications faces major challenges, such as safe delivery and gene targeting efficiency. Cas9 is a foreign protein to recipient cells; th...
Autores principales: | Xia, Emily, Duan, Rongqi, Shi, Fushan, Seigel, Kyle E., Grasemann, Hartmut, Hu, Jim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278715/ https://www.ncbi.nlm.nih.gov/pubmed/30513454 http://dx.doi.org/10.1016/j.omtn.2018.10.015 |
Ejemplares similares
-
Overcoming Self-Incompatibility in Diploid Potato Using CRISPR-Cas9
por: Enciso-Rodriguez, Felix, et al.
Publicado: (2019) -
Overcoming Immunological Challenges to Helper-Dependent Adenoviral Vector-Mediated Long-Term CFTR Expression in Mouse Airways
por: Cao, Huibi, et al.
Publicado: (2020) -
Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity
por: Landsberger, Mariann, et al.
Publicado: (2018) -
Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy
por: Rasul, Mohammed Fatih, et al.
Publicado: (2022) -
CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer
por: Vaghari-Tabari, Mostafa, et al.
Publicado: (2022)